|
| InsiderPie Expert Score
| P/E ratio
| Net margin
| ROA
| Net income per employee
|
| NantHealth, Inc.
|
50
/ 100
| -0.0043
| -109.5%
| -48.0%
| -€164.45K
|
| Phreesia, Inc.
|
45
/ 100
| -70
| -5.3%
| -5.9%
| -€9.85K
|
| Teladoc Health, Inc.
|
49
/ 100
| -7.1
| -8.2%
| -7.2%
| -€38.28K
|
| HealthStream, Inc.
|
50
/ 100
| 41
| 6.9%
| 4.1%
| €16.02K
|
| National Research Corporation
|
50
/ 100
| 21
| 12.8%
| 12.7%
| €41.56K
|
| HealthEquity, Inc.
|
53
/ 100
| 62
| 11.5%
| 4.3%
| €40.06K
|
| Spok Holdings, Inc.
|
45
/ 100
| 16
| 16.2%
| 10.9%
| €46.60K
|
| Ascom Holding AG
|
50
/ 100
| 6.2
| 3.6%
| 11.1%
| €15.96K
|
| Health Catalyst, Inc.
|
50
/ 100
| -2.6
| -31.7%
| -16.2%
| -€56.93K
|
| Cannabis Sativa, Inc.
|
50
/ 100
| -2.9
| -204.2%
| -70.8%
| -€313.53K
|
| DocCheck AG
|
50
/ 100
| 7.8
| 7.0%
| 12.4%
| €20.25K
|
| SomaLogic, Inc.
|
50
/ 100
| -3
| -159.5%
| -23.1%
| -€246.58K
|
| RaySearch Laboratories AB (publ)
|
51
/ 100
| 56
| 15.4%
| 9.7%
| €41.54K
|
| Computer Programs and Systems, Inc.
|
50
/ 100
| -5.6
| -6.9%
| -6.1%
| -€8.15K
|
| Surgical Science Sweden AB (publ)
|
50
/ 100
| 86
| 9.8%
| 2.0%
| €30.22K
|
| Ontrak, Inc.
|
50
/ 100
| -0.084
| -274.2%
| -152.8%
| -€229.00K
|
| CompuGroup Medical SE & Co. KGaA
|
56
/ 100
| 43
| 2.3%
| 1.3%
| €3.25K
|
| Craneware plc
|
53
/ 100
| 41
| 6.4%
| 4.3%
| €27.68K
|
| Veeva Systems Inc.
|
61
/ 100
| 57
| 27.3%
| 10.1%
| €94.75K
|
| Tabula Rasa HealthCare, Inc.
|
50
/ 100
| -4.6
| -18.1%
| -17.2%
| -€50.81K
|
| Omnicell, Inc.
|
55
/ 100
| 60
| 2.0%
| 1.1%
| €5.44K
|
| 10x Genomics, Inc.
|
53
/ 100
| -17
| -13.1%
| -8.6%
| -€55.25K
|
| ifa systems AG
|
50
/ 100
| 16
| 5.2%
| 3.0%
| €6.14K
|
| Renalytix Plc
|
50
/ 100
| -0.8
| -1,191.8%
| -584.7%
| -€234.39K
|
| Nexus AG
|
50
/ 100
| 36
| 12.5%
| 7.2%
| €17.92K
|
| CareCloud, Inc.
|
50
/ 100
| 0
| 8.9%
| 13.2%
| €2.06K
|
| Healthcare Triangle, Inc.
|
50
/ 100
| -1.7
| -47.7%
| -38.9%
| -€134.22K
|
| Cegedim SA
|
50
/ 100
| -7
| -2.7%
| -2.3%
| -€3.34K
|
| Evolent Health, Inc.
|
50
/ 100
| -8.1
| -7.4%
| -6.6%
| -€30.64K
|
| Accolade, Inc.
|
50
/ 100
| -3.2
| -40.4%
| -27.8%
| -€64.08K
|
| SCWorx Corp.
|
50
/ 100
| -0.51
| -105.8%
| -45.2%
| -€365.87K
|
